GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Avalon Globocare Corp (NAS:ALBT) » Definitions » EV-to-Revenue

Avalon Globocare (Avalon Globocare) EV-to-Revenue : 24.90 (As of Apr. 28, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Avalon Globocare EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Avalon Globocare's enterprise value is $31.25 Mil. Avalon Globocare's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $1.26 Mil. Therefore, Avalon Globocare's EV-to-Revenue for today is 24.90.

The historical rank and industry rank for Avalon Globocare's EV-to-Revenue or its related term are showing as below:

ALBT' s EV-to-Revenue Range Over the Past 10 Years
Min: 24.81   Med: 70.86   Max: 458.72
Current: 24.9

During the past 10 years, the highest EV-to-Revenue of Avalon Globocare was 458.72. The lowest was 24.81. And the median was 70.86.

ALBT's EV-to-Revenue is ranked worse than
91.21% of 1787 companies
in the Real Estate industry
Industry Median: 4.33 vs ALBT: 24.90

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-28), Avalon Globocare's stock price is $0.2728. Avalon Globocare's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.12. Therefore, Avalon Globocare's PS Ratio for today is 2.27.


Avalon Globocare EV-to-Revenue Historical Data

The historical data trend for Avalon Globocare's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avalon Globocare EV-to-Revenue Chart

Avalon Globocare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 96.71 69.05 53.93 52.73 26.70

Avalon Globocare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.73 37.33 35.39 29.70 26.70

Competitive Comparison of Avalon Globocare's EV-to-Revenue

For the Real Estate Services subindustry, Avalon Globocare's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avalon Globocare's EV-to-Revenue Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, Avalon Globocare's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Avalon Globocare's EV-to-Revenue falls into.



Avalon Globocare EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Avalon Globocare's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=31.250/1.255
=24.90

Avalon Globocare's current Enterprise Value is $31.25 Mil.
Avalon Globocare's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avalon Globocare  (NAS:ALBT) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Avalon Globocare's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.2728/0.12
=2.27

Avalon Globocare's share price for today is $0.2728.
Avalon Globocare's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.12.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avalon Globocare EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Avalon Globocare's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Avalon Globocare (Avalon Globocare) Business Description

Traded in Other Exchanges
N/A
Address
4400 Route 9 South, Suite 3100, Freehold, NJ, USA, 07728
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. It has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
Executives
Lourdes Felix director 15 CALLE VERANO, RANCHO SANTA MARGARITA CA 92688
W J Tauzin director 901 HUGH WALLIS ROAD S, LAFAYETTE LA 70508
Wenzhao Lu director, 10 percent owner C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Steven Andrew Sanders director 431 EAST 20TH STREET, NEW YORK NY 10010
Yancen Lu director 14009 SE 50TH STREET, BELLEVUE WA 98006
Stilley William B. Iii director 1180 SEMINOLE TRAIL, SUITE 495, CHARLOTTESVILLE VA 22901
Tevi Troy director 611 SOMERSWORTH WAY, SILVER SPRING MD 20902
Luisa Ingargiola officer: Chief Financial Officer 4826 BLUE JAY CIRCLE, PALM HARBOR FL 34683
David Jin director, officer: CEO and President C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Yue Charles Li director C/O AVALON GLOBOCARE CORP., 4400 ROUTE 9 SOUTH, SUITE 3100, FREEHOLD NJ 07728
Meng Li director, officer: Chief Operating Officer C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Steven Philip Sukel director 33 ALPINE DRIVE, MORGANVILLE NJ 07751

Avalon Globocare (Avalon Globocare) Headlines

From GuruFocus

Avalon GloboCare Announces the Deployment of Breakthrough Fusion Gene Map Technology

By Stock market mentor Stock market mentor 01-03-2023

Avalon GloboCare to Present at the Jefferies 2022 Healthcare Conference

By GuruFocusNews GuruFocusNews 07-04-2022

Avalon GloboCare to Present at the Jefferies 2022 Healthcare Conference

By GuruFocusNews GuruFocusNews 06-24-2022